Niro Ananda is a corporate advisory / M&A lawyer who specialises in advising private equity clients and their portfolio companies across all types of M&A transactions, including private and public M&A, securities offerings and capital restructures.

His clients include some of Australia's largest private equity firms such as Ironbridge Capital, Pacific Equity Partners, Archer Capital and Quadrant Private Equity as well as global private equity firms and financial sponsors such as Bain Capital, Providence Equity Partners and Intermediate Capital Group.

Niro has expertise in a wide range of industries including IT, retail, health, manufacturing and FMCG, having advised private equity portfolio company clients as well as corporate clients in those industries.

Read More

Expertise

Expand all

Corporate / M&A

Niro acted for accounting software provider MYOB Group Limited (a Bain Capital portfolio company) on its initial public offering and ASX listing with a market capitalisation of over A$2 billion, making it the largest technology IPO on the ASX (2015). 

Niro advised the funds advised by Pacific Equity Partners in respect of the $1.75 billion IPO of Spotless Group Holdings Limited (2014).

Niro advised a private equity bidder on the potential acquisition of Crown Castle Australia (sold for A$2 billion) (2015).

Niro advised TJX Companies Inc on its acquisition of the Trade Secrets business (2015).

See Corporate / M&A

Private Equity

Niro advised Pacific Equity Partners on its block trade sales in Spotless Group and Veda Group with an aggregate value of approximately A$2 billion (2014/15).

Niro advised Intermediate Capital Group on the sale of its equity in Hoyts (2014).

Niro advised Intermediate Capital Group on the MBO of Cura Day Hospitals from Archer Capital (2014).

Niro advised Ironbridge Capital in connection with the sale of a majority interest in Super A-Mart to Quadrant Private Equity (2012).

Niro advised a private equity bidder on the potential acquisition of Crown Castle Australia (sold for A$ 2 billion) (2015).

Niro advised TJX Companies Inc on its acquisition of the Trade Secrets business (2015).

Niro acted for accounting software provider MYOB Group Limited (a Bain Capital portfolio company) on its initial public offering and ASX listing with a market capitalisation of over A$2 billion, making it the largest technology IPO on the ASX (2015).

Niro advised Monash IVF Group Limited (and major shareholder Ironbridge Capital) on its A$427.5 million initial public offering (2014).

Niro advised the funds advised by Pacific Equity Partners in respect of the $1.75 billion IPO of Spotless Group Holdings Limited (2014).

See Private Equity

Mergers and Acquisitions

Niro advised a private equity bidder on the potential acquisition of Crown Castle Australia (sold for A$2 billion) (2015).

Niro advised TJX Companies Inc on its acquisition of the Trade Secrets business (2015).

Niro advised Ironbridge Capital on its sale of Southern Cross Dental Laboratories to Modern Dental Group (2015).

Niro advised MYOB Group (a Bain Capital portfolio company) in connection with the acquisition of the BankLink business from Media Transfer Services Limited for NZ$136 million (2013).

Niro is acting as Australian Counsel to Bain Capital on its A$1.2 billion acquisition of MYOB Ltd, Australia's largest independent software vendor, from a consortium led by Archer Capital (2011).

See Mergers and Acquisitions

Equity Capital Markets

Niro acted for accounting software provider MYOB Group Limited (a Bain Capital portfolio company) on its initial public offering and ASX listing with a market capitalisation of over A$2 billion, making it the largest technology IPO on the ASX (2015).

Niro advised Monash IVF Group Limited (and major shareholder Ironbridge Capital) on its A$427.5 million initial public offering (2014).

Niro advised the funds advised by Pacific Equity Partners in respect of the $1.75 billion IPO of Spotless Group Holdings Limited (2014).

Niro advised MYOB Finance Australia Limited (a Bain Capital portfolio company) on its A$155 million offer of subordinated notes (2012).

See Equity Capital Markets/IPOs

Knowledge

    Related knowledge information is loading